Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kiddi Pharmaton Fizz is a pediatric multivitamin and multimineral dietary supplement formulated as an effervescent tablet. It is designed to support the physical and mental development of children by providing essential nutrients, including B-complex vitamins (B1, B2, B6, B12), vitamins C and D, folic acid, biotin, and minerals such as calcium, iron, zinc, and copper, along with the essential amino acid lysine. Developed by Ginsana SA and marketed under the Pharmaton brand by Boehringer Ingelheim, it is primarily indicated for the prevention and treatment of vitamin and mineral deficiencies. The product aims to support cognitive function, energy metabolism, and bone health in children aged 6 to 14 years.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kiddi Pharmaton Fizz.